Majority of volume from CXXT trades today.
Rising volume, with a rising share price, leading into the quarterly next week could signal some good numbers.
Hoping the quarterly is backed up with a news/customer announcement in May.
If the majority of updates is mandatory finance reporting, compliance notices and *cough* employee incentive options, the market gets bored waiting for the next round of financials.
They need to sign another UK pharmacy chain. When I read the Day Lewis updates, I interpret them as a lost customer. Constant delays, using COVID as the issue (when pharmacies would be running hot) and suggesting rollout will resume (not be completed) in 6 months+, doesn't scream urgent to me. Happy to see them convert, but I'm not holding my breath.
Hopefully the additional integration work with other NHS systems will see them hook someone from 'the growing pipeline of engaged pharmacies'.
The war chest would take a hit having to payout Adheris, but I believe they would have factored this in as a possibility when they did the deal and raise, so there should still be ~$15M.
Add to My Watchlist
What is My Watchlist?
